Atlas Trials

Dose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on Hemodialysis

Clinical trial NCT01736150 · COMPLETED

Trial details

NCT number
NCT01736150
Sponsor
Genzyme, a Sanofi Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Kidney DiseaseChronic Kidney Disease on Hemodialysis
Start date
2010-03-01
Primary completion
2010-09-01
Enrollment
205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.